← Back to Clinical Trials
Recruiting Phase 4 NCT07427446
Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium
Trial Parameters
Condition Emergence Delirium
Sponsor Kasr El Aini Hospital
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 50
Sex ALL
Min Age 2 Years
Max Age 6 Years
Start Date 2026-02-01
Completion 2026-12
Interventions
Dexmedetomidine and MidazolamKetamine and Midazolam
Brief Summary
Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)
Eligibility Criteria
Inclusion Criteria: * Scheduled for elective cardiac catheterization under general anesthesia. Exclusion Criteria: * neurological disorder, psychiatric disease, or current psychoactive medication. * allergy. * significant systemic comorbidities.